Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.

Cardiologists detail long-term outcomes of valve-in-valve TMVR

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

Thumbnail

Pulsed-field ablation as safe and effective as thermal ablation when treating paroxysmal AFib

Boston Scientific, which funded the study, hopes these results can help the company gain FDA approval for its PFA device in the months ahead. 

Withings Body Scan Connected Health Station FDA cleared

FDA clears new smart scale capable of detecting AFib, other cardiovascular issues

The Body Scan Connected Health Station includes a high-strength glass platform with four weight sensors and 14 ITO electrodes and a retractable handle with four stainless steel electrodes.

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 

cardiologist doctor physician patient black diverse hypertension

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."

amsterdam the netherlands

ESC Congress 2023: 4 key sessions scheduled for world’s largest gathering of cardiology professionals

The four-day event in Amsterdam officially begins on Friday, Aug. 25. Read our sneak preview of some of the conference's key sessions.